Albany Molecular Research (AMRI) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q2 EPS of $0.22, $0.02 better than the analyst estimate of $0.20. Revenue for the quarter came in at $68.2 million versus the consensus estimate of $65.64 million.
Albany Molecular Research sees FY2014 EPS of $0.87-$0.92, versus the consensus of $0.92.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Freedom Broker Upgrades Willis Lease Finance Corp. (WLFC) to Buy
- Goldman Sachs expects July core PCE to rise 0.23%
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
